人深静脉靶向基因表达分析:瓣膜与管壁的差异
研究前瞻性收集膝上截肢患者正常股静脉瓣膜段,分四区用实时定量PCR和western blot检测凝血、纤溶和炎症相关基因。发现瓣膜尖抗血栓基因PROCR、THBD、TFPI及促血栓VWF、促炎SELP、ICAM1表达均上调,PROCR和THBD上调最显著;瓣膜尖内皮可能天然致血栓性较低但白细胞相互作用潜能较高。
要点
- 深静脉瓣膜尖抗血栓与促炎基因表达均高于管壁,PROCR和THBD上调最显著。
- 瓣膜尖PROCR、SERPINE1和SELP蛋白水平亦上调。
- 瓣膜尖内皮可能天然致血栓性较低,但白细胞相互作用潜能较高。
核心结论
- 正常深静脉瓣膜尖、瓣膜内管壁及瓣膜外管壁生物学特性不同。
- 瓣膜尖内皮可能天然致血栓性较低,但白细胞相互作用潜能较高。
研究设计与样本
- 前瞻性收集膝上截肢患者宏观完整且功能良好的含瓣膜深静脉段。
- 将静脉样本分为瓣膜下游近端管壁、瓣膜尖、瓣膜上游远端管壁和瓣膜内管壁四区。
- 用实时定量PCR检测凝血、纤溶和炎症主要基因的mRNA,western blot检测选定蛋白产物,并对1个含瓣膜段行质谱分析。
主要发现
- 瓣膜尖抗血栓基因PROCR、THBD、TFPI,促血栓基因VWF及促炎基因SELP、ICAM1较管壁显著上调(P < .05)。
- PROCR和THBD在瓣膜尖上调水平最高。
- 瓣膜尖PROCR、SERPINE1和SELP在蛋白水平上调(P < .05)。
- 瓣膜内管壁mRNA组成除ICAM1过表达两倍(P < .05)外,其余基因与瓣膜上游和下游管壁相似。
临床怎么用
- 加深对正常人深静脉生物学的理解,为深静脉血栓形成发病机制的新假说奠定基础。
- 可能提示新的治疗策略研究方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Endothelial-derived molecules involved in thrombosis and hemostasis have been investigated mainly in arteries and in experimental animals. The actual presence and integral function of these molecules in the human deep venous system have received less attention. Our aim was to evaluate the expression of certain prothrombotic and antithrombotic genes in the normal human deep veins of the lower extremities. METHODS: Macroscopically intact and competent valve-containing segments of human deep veins were prospectively collected from patients who had undergone above-knee amputation. Vein samples were separated into four zones: zone 1, postvalve (downstream, proximal) vein wall; zone 2, the valve cusp; zone 3, prevalve (upstream, distal) vein wall; and zone 4, vein wall within the valve cusp (cusp removed). Real-time quantitative polymerase chain reaction for principal genes involved in coagulation, fibrinolysis, and inflammation was performed to quantify messenger RNA. Selected protein gene products were measured by the western blot assay. One additional valve-containing segment underwent mass spectrometry analysis to investigate global differences in the proteome between the study zones. RESULTS: Seventeen valve-containing vein segments were analyzed. Significant upregulation of antithrombotic (protein C receptor [PROCR], thrombomodulin [THBD], tissue factor pathway inhibitor [TFPI]), prothrombotic (con Willebrand factor [VWF]), and proinflammatory (selectin P [SELP], intercellular adhesion molecule 1 [ICAM1]) genes was found in the valve cusp compared with the vein wall (P < .05). PROCR and THBD demonstrated the highest level of upregulation in the valve cusp. PROCR, serpin peptidase inhibitor, clade E, member 1 (SERPINE1), and SELP were upregulated in the valve cusp at the protein level (P < .05). Messenger RNA composition in the vein wall within the valve cusp was similar to the prevalve and postvalve vein wall for all genes, except for two times overexpressed ICAM1 (P < .05). Substantial differences within the proteome between the study zones were observed with mass spectrometry. CONCLUSIONS: The biological properties of the valve cusp, vein wall within the valve cusp, and vein wall beyond the valve cusp are different. The endothelium of the valve cusps of a normal competent deep venous valve may be naturally less thrombogenic compared with the vein wall. The endothelium of the valve cusp may have a higher potential to interact with white blood cells compared with the vein wall. Mass spectrometry demonstrates substantial differences in the proteome between the vein wall and the valve cusps that were not anticipated before. (J Vasc Surg Venous Lymphat Disord 2021;9:770-80.) CLINICAL RELEVANCE: Deep vein thrombosis (DVT) is a major cause of mortality, morbidity, and impaired quality of life. Multiple risk factors have been identified, although their relative weight and pathophysiologic interactions remain obscure. Many patients with multiple risk factors for DVT never develop this condition. Conversely, in numerous cases DVT cannot be attributed to any known clinical risk factor. The molecular mechanisms that initiate DVT are unclear. An improved understanding of the normal biology of human deep veins will serve as an important foundation for new hypotheses of the pathogenesis of DVT. The latter may suggest new projects on novel therapeutic strategies.
引用
- Shaydakov ME, Diaz JA, Comerota AJ, et al. Targeted gene expression analysis of human deep veins. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32860957. doi:10.1016/j.jvsv.2020.08.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。